Skip to main content
SpringerLink
Log in

Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine

  • Short Communication
  • Metastatic Renal Cancer, CCNU, Vinblastine
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

No remission was achieved in 15 evaluable patients with measurable metastatic renal cancer treated with CCNU 120 mg/m2 (day 1) and vinblastine 0.1 mg/kg body weight (days 1 and 8) repeated every 6th week. Two additional patients were not evaluable for response owing to early death from progressive disease.

Previously reported beneficial response rates in metastatic renal cancer after treatment with CCNU and vinblastine could not be confirmed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Davis TE, Manalo FB (1978) Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine. Proc ASCO 19:316

    Google Scholar 

  2. Decker DA, Samson MJ, Baker LH (1983) PCNU in advanced adenocarcinoma of the ovary: A phase II study. Cancer Treat Rep 67:511–512

    Google Scholar 

  3. Failand DJ (1981) Spontaneous regression of metastases of renal cancer. Cancer 47:2101–2106

    Google Scholar 

  4. Hahn DM, Schimpff SC, Ruckdeschel JC, Wiernik PH (1977) Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin. Cancer Treat Rep 61:1585–1587

    Google Scholar 

  5. Hahn RG, Colin BB, Davis T (1981) Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer. Cancer Treat Rep 65:711–714

    Google Scholar 

  6. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Department, The Norwegian Radium Hospital, Oslo, Norway

    Hilde Heen Sommer & Sophie Dorothea Fosså

  2. Department of Diagnostic Radiology, The Norwegian Radium Hospital, Oslo, Norway

    Hans Henrik Lien

Authors
  1. Hilde Heen Sommer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Dorothea Fosså
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Henrik Lien
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sommer, H.H., Fosså, S.D. & Lien, H.H. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine. Cancer Chemother. Pharmacol. 14, 277–278 (1985). https://doi.org/10.1007/BF00258134

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00258134

Keywords

Search

Navigation